Clearmind Medicine (CMND) Operating Expenses (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Operating Expenses of $1.6 million for Q2 2026, up 20.22% year-over-year from $1.3 million in Q2 2025, and down 57.07% quarter-over-quarter from $3.7 million in Q1 2026.
Clearmind Medicine (CMND) Operating Expenses (2022 - 2026) Analysis & Trends
Clearmind Medicine's Operating Expenses history runs 5 years deep, the most recent figure standing at $1.6 million for Q2 2026.
- In Q2 2026, Operating Expenses rose 20.22% year-over-year to $1.6 million; the TTM figure through Apr 2026 stood at $8.1 million (up 38.13% YoY), while the FY2025 annual figure was $5.7 million, down 1.35% from the prior year.
- Operating Expenses for Q2 2026 stood at $1.6 million, down from $3.7 million in the prior quarter.
- The five-year high for Operating Expenses was $3.7 million in Q1 2026, with the low at $1.1 million in Q3 2023.
- The 5-year median for Operating Expenses is $1.5 million (2024), against an average of $1.6 million.
- The sharpest annual moves came in 2023 and 2026: Operating Expenses slumped 30.2% in 2023, then soared 144.62% in 2026.
- Clearmind Medicine's Operating Expenses stood at $1.4 million in 2022, then increased by 26.69% to $1.7 million in 2023, then decreased by 7.32% to $1.6 million in 2024, then fell by 8.19% to $1.5 million in 2025, then grew by 7.89% to $1.6 million in 2026.
- Business Quant data shows CMND's Operating Expenses at $1.6 million in Q2 2026, $3.7 million in Q1 2026, and $1.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.57 Mn |
| Jan 31, 2026 | 3.66 Mn |
| Oct 31, 2025 | 1.46 Mn |
| Jul 31, 2025 | 1.41 Mn |
| Apr 30, 2025 | 1.31 Mn |
| Jan 31, 2025 | 1.50 Mn |
| Oct 31, 2024 | 1.59 Mn |
| Jul 31, 2024 | 1.47 Mn |
| Apr 30, 2024 | 1.30 Mn |
| Jan 31, 2024 | 1.38 Mn |
| Oct 31, 2023 | 1.71 Mn |
| Jul 31, 2023 | 1.10 Mn |
| Apr 30, 2023 | 1.22 Mn |
| Jan 31, 2023 | 1.83 Mn |
| Jul 31, 2022 | 1.35 Mn |
| Apr 30, 2022 | 1.75 Mn |
| Jan 31, 2022 | 1.65 Mn |